As we transition into 2025, several key issues from 2024 will continue to impact the pharmacy benefit landscape, along with a few new developments…
At National CooperativeRx, we take pride in fostering professional growth and celebrating the achievements of our team members. As the year comes to a close, we are thrilled to recognize several internal promotions…
Expect another year of non-specialty drugs surpassing specialty drugs in their overall contributions to trend. GLP-1s will continue to be major drivers.
We are pleased to add Lexi Yonkovic to the National CooperativeRx team! As a strategic account executive, Lexi will build and maintain strong relationships with member groups …
As a sales and account associate, Zach supports our strategic account executives and clinical team in fostering relationships with existing members and partners.
Offering rebates has been a pricing strategy for manufacturers of brand-named prescription drugs for decades. The explosion of rebate value has happened over the last 10-12 years as pharmacy benefit managers (PBMs)
